SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Bayer HealthCare Pharmaceuticals's Stivarga® (Regorafenib) Tablets New Drug Application Granted Priority Review by U.S. FDA for the Treatment of Patients with Gastrointestinal Stromal Tumors